Program Management & Optimization Flashcards
7 cards from real ACE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Program Management & Optimization flashcards as text
A 340B program manager is implementing a new workflow to improve medication adherence among 340B-eligible patients. Which intervention is best supported by 340B program goals?
Answer: Using 340B savings to fund pharmacist-led medication therapy management services
Using 340B savings to fund clinical services like MTM directly supports the program's mission of improving care for underserved populations and is a well-recognized appropriate use.
Which of the following best characterizes the relationship between the 340B program and the GPO prohibition for certain covered entities?
Answer: DSH hospitals and certain other entities may not use GPOs for covered outpatient drugs while participating in 340B
Disproportionate share hospitals (DSH) and certain other entities face a GPO prohibition on covered outpatient drugs under the 340B statute, though exceptions exist for some drug categories.
An ACE candidate is reviewing a covered entity's contract pharmacy arrangement. Which element is NOT required to be included in the contract pharmacy agreement according to HRSA guidance?
Answer: A price guarantee from the manufacturer for sub-ceiling pricing
HRSA contract pharmacy guidance does not require manufacturer price guarantees in the agreement; the agreement governs the relationship between the covered entity and the pharmacy, not the manufacturer.
A 340B-eligible patient is seen at a covered entity's registered child site. The prescription is filled at a non-registered contract pharmacy location. What is the compliance status?
Answer: Non-compliant, because the dispensing pharmacy must also be a registered contract pharmacy location
Both the patient encounter site and the dispensing pharmacy must be properly registered; using an unregistered pharmacy location to dispense 340B drugs violates program requirements.
Which performance indicator would best demonstrate that a 340B program is effectively serving its mission population?
Answer: Percentage of 340B patients who are uninsured, underinsured, or low-income
Tracking the proportion of 340B patients from vulnerable populations demonstrates alignment with the program's mission to serve those with limited access to care.
A covered entity receives a manufacturer's survey requesting detailed patient-level 340B claims data. How should the 340B program manager respond?
Answer: Consult legal counsel and HRSA guidance before disclosing any patient-level data
Patient-level data disclosure involves privacy regulations (HIPAA) and evolving 340B policy; legal counsel and HRSA guidance should be consulted before any response is made.
What is the primary purpose of conducting a 340B self-audit or internal compliance review?
Answer: To proactively identify and correct compliance gaps before a formal HRSA audit
Internal self-audits allow covered entities to identify and remediate compliance issues proactively, reducing the risk of findings and sanctions during formal HRSA audits.